Encompass Health (AMEX:EHC) Price Target Raised to $100.00

Encompass Health (AMEX:EHC) had its target price raised by SunTrust Banks from $90.00 to $100.00 in a report released on Monday, The Fly reports. They currently have a buy rating on the stock. SunTrust Banks also issued estimates for Encompass Health’s Q1 2020 earnings at $0.83 EPS, Q2 2020 earnings at $0.90 EPS, Q3 2020 earnings at $0.86 EPS, Q4 2020 earnings at $0.90 EPS, FY2020 earnings at $3.50 EPS and FY2021 earnings at $3.95 EPS.

A number of other equities research analysts also recently weighed in on the stock. UBS Group boosted their price objective on shares of Encompass Health from $80.00 to $87.00 and gave the company a buy rating in a research report on Friday, January 10th. Jefferies Financial Group lifted their target price on Encompass Health from to in a research note on Monday, January 13th. Wells Fargo & Co lowered Encompass Health from a market perform rating to an underperform rating and set a $68.00 target price for the company. in a report on Wednesday, December 11th. Mizuho reiterated a buy rating and set a $87.00 price target (up from $84.00) on shares of Encompass Health in a research report on Monday. Finally, Zacks Investment Research raised Encompass Health from a hold rating to a buy rating and set a $78.00 price target on the stock in a report on Tuesday, December 31st. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and fourteen have assigned a buy rating to the stock. The stock presently has a consensus rating of Buy and an average target price of $81.12.

Encompass Health has a one year low of $40.86 and a one year high of $59.29.

Encompass Health (AMEX:EHC) last released its earnings results on Thursday, February 6th. The company reported $0.85 earnings per share for the quarter, missing the consensus estimate of $0.87 by ($0.02). The business had revenue of $1.18 billion for the quarter, compared to analysts’ expectations of $1.18 billion. During the same period last year, the firm posted $0.80 EPS. Encompass Health’s revenue was up 8.1% compared to the same quarter last year.

About Encompass Health

Encompass Health Corporation, formerly HealthSouth Corporation, is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies.

Further Reading: Trading Ex-Dividend

The Fly

Analyst Recommendations for Encompass Health (AMEX:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit